Markets & Stocks
Stay informed about the latest developments and trends in the cannabis stock market with Business of Cannabis. Discover new investment opportunities, market analysis, and more in our stocks category.
Markets & Stocks · page 11
- Markets & Stocks
Could Rescheduling Finally Bring Institutional Investment in to Cannabis?
Cannabis rescheduling in the US, a landmark legislative move that has held the attention of the global cannabis industry since it was first proposed in August last year, was officially backed by the Biden administration last week for the first time.
- Markets & Stocks
Cantourage & Celadon Announce Double Digit Growth in 2023, Hellenic Dynamics Announces Further Fundraise
Celadon Pharmaceuticals [stock_market_widget type=”chart” template=”line” assets=”CEL.L” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] Celadon Pharmaceuticals this week released its full-year results for 2023, reporting revenues over three times those seen in 2022.
- Companies
Oxford Cannabinoid Technologies Delisting From LSE May Not ‘Be The Last’
Last week, UK biotechnology firm Oxford Cannabinoid Technologies (OCT), one of the first cannabis companies in history to list on the London Stock Exchange (LSE), informed investors of its intention to leave.
- Companies
Curaleaf, Trulieve, Green Thumb & Verano Report Q1 Earnings as Losses Continue to Shrink
This week, a swathe of North America’s largest cannabis companies reported thier most recent financial results, revealing slimming but continued losses almost unanimously.
- Markets & Stocks
SynBiotic Acquires German Wholesaler Weeco as Clever Leaves & OCT Reveal Plans to Delist as Stocks Struggle
Synbiotic [stock_market_widget type=”chart” template=”line” assets=”SBX.DE” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] German cannabis group SynBiotic has capitalised on the recent explosion in medical cannabis patients since the country’s landmark CanG came into effect last month.
- Markets & Stocks
Cannabis Stocks Fly on Rescheduling News, Kanabo Revenues Jump 48%, & Apollon to Delist Stock
North American cannabis stocks fly on DEA decision On Tuesday (April 30), news broke via a leak to the press that the US Drug Enforcement Administration (DEA) is set to approve the rescheduling of cannabis, a move expected to have a significant impact on the cannabis industry across the globe.
- Markets & Stocks
Chill Brands CEO Suspended Amid Allegations Of ‘Use of Inside Information’, SynBiotic Buys Croatian CBD Maker, & Hellenic Secures Funding
Chill Brands [stock_market_widget type=”chart” template=”line” assets=”CHLL.L” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] Chill Brands has seen its share price dive by nearly 40% this week after news emerged that its CEO, Callum Sommerton, had been suspended amid allegations of insider trading.
- Markets & Stocks
OCT Announces 2nd Clinical Trial, Chill Brands Investor Calls For Director Ousting, & More From SEED
Oxford Cannabinoid Technologies [stock_market_widget type=”chart” template=”line” assets=”OCTP.L” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] Oxford Cannabinoid Technologies (OCT) has announced plans to launch a Phase 1 clinical trial into a second compound after partnering with Australian contract research organisation (CRO) iNGENū.
- Markets & Stocks
Merger Falls Apart As Northern Leaf & Voyager Life Fail To Raise Capital, & Curaleaf Eyes Secondary Listing In Germany
Curaleaf [stock_market_widget type=”chart” template=”line” assets=”CURLF” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] Canadian Stock Exchange-listed Curaleaf, the largest grower and distributor of cannabis in the world, is reportedly exploring a secondary listing in Germany.
- Markets & Stocks
IMC Stock Jumps Over 60%, Akanda Announces New Strategic Plan, & MGC Becomes Argent BioPharma
IM Cannabis [stock_market_widget type=”chart” template=”line” assets=”IMCC” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] IM Cannabis has seen its share price skyrocket by over 65% this week, despite reporting a 10% decline in revenues and over $10m in net losses in 2023.
- Markets & Stocks
CanG’s Passage Drives Up Global Cannabis Stock Prices, & Jazz Pharma Pays $7.5m To Settle Lawsuit Over GW Acquisition
Germany’s passage of CanG continues to drive up stock prices Yesterday, the President of Bundesrat, Manuela Schwesig, signed Germany’s landmark CanG bill, meaning it is now all but certain to be brought into law on April 01.
- Markets & Stocks
Love Hemp Falls Into Administration for Second Time, Akanda To Issue New Share Offering, & More from Kanabo
Love Hemp The formerly Aquis-listed UK CBD retailer, which collapsed into administration and saw its shares withdrawn in February last year, has called in administrators once again.
